Designation Attests to High Quality and Purity of Process, Product
IRVING, Texas, Jan. 9 -- Carrington Laboratories, Inc. (Nasdaq: CARN) today announced that its freeze- dried Manapol(R) nutraceutical material produced and packaged in Carrington's Costa Rica facilities has been certified to be "Kosher Parve," meaning it meets exacting standards for cleanliness of facilities and for production and packaging processes, and is free of any meat, foul or dairy products or byproducts.
"We sought this certification to meet the needs of existing customers as well as to expand potential markets for Manapol(R) and Manapol(R)-based products," said Walt Jones, president of Caraloe, Inc., Carrington's consumer products subsidiary. "In addition to the obvious religious implications under Orthodox Jewish law, Kosher Parve certification assures all users -- including vegetarians and lactose intolerant people -- that Manapol(R) is of the highest quality. In order to maintain this certification, our Costa Rica facilities undergo quarterly inspections of all associated products, packaging, manufacturing procedures, machinery and cleanliness. These inspections frequently are conducted to standards even more stringent than those of the Food and Drug Administration."
Rabbi Gershon Miletski, chief rabbi of the Orthodox Costa Rican Community, awarded the Kosher Parve certification to Carrington and will continue to monitor production to ensure ongoing compliance.
Manapol (R) Powder is a product by process protected by patents in more than 26 countries and carries the DSHEA (Dietary Supplement Health and Education Act of 1994) claim that it enhances the immune system. "Additionally," Jones added, "along with a proper nutrition and exercise program, it may help maintain healthy cholesterol levels and act as a digestive aid." The product's major end markets include nutritional beverages, dietary supplements, and nutraceuticals.
Carrington Laboratories, Inc., is an ISO 9001-certified, research-based biopharmaceutical and consumer products company currently utilizing naturally occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care; manufacture and market the nutraceutical raw materials Manapol(R) and Hydrapol(TM). Carrington also manufactures and markets consumer products sold under its AloeCeuticals(R) brand and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. The company's DelSite subsidiary is developing its proprietary GelSite(TM) technology designed to provide controlled release of peptide- and protein-based drugs. Carrington's technology is protected by more than 120 patents in 26 countries. Select products are honored with the internationally coveted CE mark, recognized by more than 20 countries around the world.
For additional information about Carrington Laboratories, Visit http://www.carringtonlabs.com.